pharma · Multiple Sclerosis · Relapsing Remitting Multiple Sclerosis · CTNM
Contineum Therapeutics
Contineum Therapeutics clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
San Diego, USA HQ
2017 Founded
59 Employees
Public company Type
CTNM · NYSE Ticker
Company details
- Status
- Public
- HQ
- San Diego, USA
- Founded
- 2017
- Employees
- 59
- Programs
- 7
- Drugs
- 3
- Patents
- 2
Contineum Therapeutics projects
3 ClinicalTrials.gov programs sponsored by Contineum Therapeutics.
Contineum Therapeutics has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
Frequently asked questions
How many clinical projects does Contineum Therapeutics have?
3 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.